Charles Gibson
Interventional Cardiology · Boston, MANPI 1124053277
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $540,567 of the $660,609 with a category attached, or 81.8%. It is spread thinly across 31 manufacturers, the largest accounting for just 20.4%. Reporting peaked in 2019 at $162,695 and has fallen 61.8% since, to $62,218 in 2025. Among interventional cardiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $2859.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$135K
- Avertix Medical, Inc$60K
- CSL Behring$60K
- Amgen$48K
- Daiichi Sankyo Inc.$46K
- Boston Scientific$38K
- plus $274K from 25 others
Across 103 payments — averaging $151,668 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$15.3M
- Janssen Scientific Affairs, LLC$189K
- Janssen Research & Development, LLC$65K
- Amarin Pharma, Inc.$28K
- Cardiva Medical, Inc.$11K
- Portola Pharmaceuticals, LLC$9K
- plus $695 from 1 others
What the payments were for
- Consulting fees$540,56782%
- Speaking & faculty fees$57,2989%
- Travel & lodging$48,1667%
- Food & beverage$6,7791%
- Education$7,8001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 22 | $135,018 |
| Avertix Medical, Inc | 2 | $60,000 |
| CSL Behring | 32 | $59,756 |
| Amgen | 20 | $47,687 |
| Daiichi Sankyo Inc. | 7 | $46,282 |
| Boston Scientific | 25 | $38,361 |
| Amarin Pharma, Inc. | 27 | $38,201 |
| Heartflow, Inc. | 11 | $29,347 |
| E.r. Squibb & Sons, L.L.C. | 5 | $26,150 |
| Intercept Pharmaceuticals, Inc. | 4 | $23,800 |
| Chiesi USA, Inc. | 1 | $21,840 |
| Roche Diagnostics International Ltd | 6 | $16,226 |
| AMAG Pharmaceuticals, Inc. | 8 | $15,776 |
| Janssen Global Services, LLC | 10 | $15,403 |
| Merck | 11 | $14,819 |
| Johnson & Johnson | 5 | $13,517 |
| Haemonetics Corporation | 6 | $9,956 |
| Novartis | 3 | $8,712 |
| Janssen Scientific Affairs, LLC | 5 | $7,824 |
| Pfizer | 4 | $7,540 |
| Alnylam Pharmaceuticals Inc. | 1 | $5,250 |
| Genentech, Inc. | 2 | $4,799 |
| F. Hoffmann-la Roche AG | 1 | $3,220 |
| Esperion Therapeutics, Inc. | 5 | $3,164 |
| Bayer | 1 | $3,000 |
| Novo Nordisk | 2 | $2,322 |
| Boehringer Ingelheim International GmbH | 1 | $1,480 |
| AstraZeneca | 1 | $1,074 |
| Medtronic | 1 | $35 |
| Celonova Biosciences, Inc. | 1 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$69,051
- Savaysa$46,282
- Vascepa$37,811
- FFRct$29,293
- KENGREAL$21,840
- WATCHMAN FLX$19,013
- EVENITY$15,200
- FERAHEME$12,384
- Repatha$11,717
- WATCHMAN Access System$11,008
- MAKENA$10,740
- INTRAROSA$10,740
- Watchman$7,500
- TEG$5,769
- TNKase$4,720
- TEG6s HEMOSTASIS SYSTEM$4,154
- LEQVIO$3,960
- NEXLETOL$3,137
- CELEBREX$2,520
- PAXLOVID$2,500
How this compares
$660,609 in reported general payments places this provider in the 95th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Other interventional cardiology in Boston
- Eric SecemskyBoston$1.2M
- Darshan DoshiBoston$730K
- Duane PintoBoston$491K
- Robert YehBoston$412K
- Suzanne BaronBoston$274K
- Farouc JafferBoston$213K
- Joseph GarasicBoston$152K
- Pinak ShahBoston$147K
- Douglas DrachmanBoston$132K
- Hector Tamez AguilarBoston$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.